Article By:
ChinaBio® Today
Sunday, August 23, 2015 10:58 AM EDT
Burning Rock Biotech, a Guangzhou oncology diagnostics company, completed a $23 million Series A+ round of funding. The company is developing diagnostic tests for solid tumor cancers that indicate the best treatment option for each patient.